AVDL - Avadel Pharmaceuticals plc
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $0.08
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.20
DETAILS
HIGH:
$22.50
LOW:
$18.50
MEDIAN:
$20.00
CONSENSUS:
$20.20
DOWNSIDE:
6.65%
Market Cap:
2.12B
Volume:
35,016,239
Avg Volume:
2,415,222
52 Week Range:
6.38-23.57
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
1.31
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
IE
Employees:
188
IPO Date:
1996-06-07
EPS (TTM):
-0.51
P/E Ratio:
-20.48
Revenue (TTM):
169.12M
Total Assets:
164.24M
Total Debt:
1.70M
Cash & Equiv:
51.37M
Rev Growth (5Y):
23.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-33.1%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-08-07 | $0.10 | $0.02 | +400.0% | $68.1M | $73.6M | -7.4% |
| 2025-05-07 | $-0.05 | $-0.07 | +28.6% | $52.5M | $58.2M | -9.8% |
| 2025-03-03 | $-0.05 | $-0.05 | 0.0% | $50.4M | $52.5M | -4.1% |
| 2024-11-12 | $-0.03 | $-0.06 | +50.0% | $50.0M | $52.7M | -5.1% |
| 2024-08-08 | $-0.14 | $-0.17 | +17.6% | $41.5M | $48.2M | -14.0% |
| 2024-05-08 | $-0.30 | $-0.25 | -20.0% | $27.2M | $37.6M | -27.7% |
| 2024-03-04 | $-0.32 | $-0.28 | -14.3% | $19.5M | $37.6M | -48.2% |
| 2023-11-08 | $-0.41 | $-0.35 | -17.1% | $7.0M | $15.8M | -55.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 169.12M | 27.96M | 0 | 0 | 22.33M | 59.22M | 103.27M | 172.74M | 150.25M | 173.21M | 14.78M | 22.44M |
| Net Income | (48.83M) | (160.28M) | (137.46M) | (77.33M) | 7.03M | (33.23M) | (95.30M) | 67.25M | (41.28M) | 40.66M | (84.91M) | (42.92M) |
| EPS | -0.51 | -2.00 | -2.29 | -1.32 | 0.13 | -0.89 | -2.55 | 1.66 | -1.00 | 1.00 | -2.34 | -1.69 |
| Total Assets | 164.24M | 164.70M | 132.78M | 247.26M | 311.64M | 151.44M | 190.30M | 252.11M | 245.48M | 214.98M | 174.21M | 116.25M |
| Total Debt | 1.70M | 2.62M | 131.02M | 145.00M | 130.52M | 124.65M | 115.84M | 267,000 | 815,000 | 1.12M | 118.48M | 85.70M |
| Cash & Equivalents | 51.37M | 31.17M | 73.98M | 50.71M | 71.72M | 9.77M | 9.32M | 16.56M | 39.22M | 65.06M | 39.76M | 6.64M |
| Operating Cash Flow | (46.91M) | (128.51M) | (70.30M) | (77.31M) | (48.73M) | (38.33M) | (82.72M) | 16.66M | 18.90M | 84.29M | (10.62M) | (20.68M) |
| Free Cash Flow | (46.91M) | (128.51M) | (71.02M) | (77.34M) | (48.83M) | (38.35M) | (102.89M) | (37.04M) | 17.70M | 82.66M | (12.35M) | (21.70M) |
| FCF per Share | -0.49 | -1.60 | -1.18 | -1.32 | -0.92 | -1.03 | -2.76 | -0.92 | 0.43 | 2.04 | -0.34 | -0.85 |
| Book Value | 73.85M | 87.74M | (21.14M) | 78.24M | 162.27M | (29.20M) | 2.78M | 84.56M | 42.07M | 67.86M | 24.89M | (9.51M) |
| Cash & ST Investments | 73.78M | 105.11M | 96.50M | 157.22M | 221.40M | 64.16M | 99.92M | 94.08M | 154.19M | 144.80M | 92.83M | 7.04M |
| ROC Equity | -0.66 | -1.83 | N/A | -0.99 | 0.04 | N/A | -34.28 | 0.80 | -0.98 | 0.60 | -3.41 | N/A |